Cargando…

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada

BACKGROUND: A simplified Canadian definition was recently developed to enable identification of individuals with familial hypercholesterolemia (FH) and severe hypercholesterolemia in the general population. Our objective was to use a modified version of this new definition to assess contemporary dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akioyamen, Leo E., Chu, Anna, Genest, Jacques, Lee, Douglas S., Abdel-Qadir, Husam, Jackevicius, Cynthia A., Lawler, Patrick R., Sud, Maneesh, Udell, Jacob A., Wijeysundera, Harindra C., Ko, Dennis T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486867/ https://www.ncbi.nlm.nih.gov/pubmed/36148251 http://dx.doi.org/10.1016/j.cjco.2022.05.003

Ejemplares similares

Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
por: Udell, Jacob A., et al.
Publicado: (2022)

Variation and clinical consequences of wait-times for atrial fibrillation ablation: population level study in Ontario, Canada
por: Qeska, Denis, et al.
Publicado: (2023)

Sex-Based Differences in Severe Outcomes, Including Cardiovascular Hospitalization, in Adults With COVID-19 in Ontario, Canada
por: Behrouzi, Bahar, et al.
Publicado: (2023)

Relationship of frailty with excess mortality during the COVID-19 pandemic: a population-level study in Ontario, Canada
por: Wijeysundera, Harindra C., et al.
Publicado: (2022)

Temporal Trends and Drivers of Heart Team Utilization in Transcatheter Aortic Valve Replacement: A Population‐Based Study in Ontario, Canada
por: Marcus, Gil, et al.
Publicado: (2021)

Social Deprivation and Post‐TAVR Outcomes in Ontario, Canada: A Population‐Based Study
por: Patel, Raumil V., et al.
Publicado: (2022)

Patient, physician and geographic predictors of cardiac stress testing strategy in Ontario, Canada: a population-based study
por: Roifman, Idan, et al.
Publicado: (2022)

Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort study
por: Guerin, Amanda, et al.
Publicado: (2023)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study
por: Abdel-Qadir, Husam, et al.
Publicado: (2022)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Use of Cardiac Noninvasive Testing After Emergency Department Discharge: Association of Hospital Network Testing Intensity and Outcomes in Ontario, Canada
por: Roifman, Idan, et al.
Publicado: (2020)

Long-term Clinical Outcomes in Contemporary Patients Undergoing Left Atrial Appendage Occlusion Procedures in Ontario, Canada
por: Singh, Sheldon M., et al.
Publicado: (2023)

Profiling Hospital Performance on the Basis of Readmission After Transcatheter Aortic Valve Replacement in Ontario, Canada
por: Elbaz‐Greener, Gabby, et al.
Publicado: (2019)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
por: Ko, Dennis T., et al.
Publicado: (2018)

The Impact of the COVID-19 Pandemic on Cardiac Procedure Wait List Mortality in Ontario, Canada
por: Tam, Derrick Y., et al.
Publicado: (2021)

Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with COVID-19: a population-based cohort study
por: Abdel-Qadir, Husam, et al.
Publicado: (2023)

Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial Hypercholesterolemia
por: Ryzhaya, Natalia, et al.
Publicado: (2021)

Troponin Testing After Noncardiac Surgery in Ontario: An Observational Study
por: Azizi, Paymon M., et al.
Publicado: (2021)

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Population Trends in All‐Cause Mortality and Cause Specific–Death With Incident Atrial Fibrillation
por: Singh, Sheldon M., et al.
Publicado: (2020)

Practice Patterns and Trends in the Use of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention in Ontario
por: Garg, Pallav, et al.
Publicado: (2014)

Impact of the Publication of Appropriate Use Criteria on Utilization Rates of Myocardial Perfusion Imaging Studies in Ontario, Canada: A Population‐Based Study
por: Roifman, Idan, et al.
Publicado: (2017)

Comparison of Cardiovascular Risk Factors and Outcomes Among Practicing Physicians vs the General Population in Ontario, Canada
por: Ko, Dennis T., et al.
Publicado: (2019)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
por: Saadatagah, Seyedmohammad, et al.
Publicado: (2022)

Specialized multi-disciplinary heart failure clinics in Ontario, Canada: an environmental scan
por: Wijeysundera, Harindra C, et al.
Publicado: (2012)

Financial Incentives for Transcatheter Aortic Valve Implantation in Ontario, Canada: A Cost‐Utility Analysis
por: Peel, John K., et al.
Publicado: (2022)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
por: Ungar, Leo, et al.
Publicado: (2018)

Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy
por: Wijeysundera, Harindra C, et al.
Publicado: (2017)

Rate of COVID-19 Infection in Patients With ST-Segment Elevation Myocardial Infarction
por: Sud, Maneesh, et al.
Publicado: (2021)

Hospital‐Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome
por: Ozaki, Aya F., et al.
Publicado: (2022)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

Familial hypercholesterolemia: A review
por: Varghese, Mithun J
Publicado: (2014)

Familial Hypercholesterolemia and the Atherosclerotic Disease
por: Kim, Yoo Ri, et al.
Publicado: (2013)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jso2sguc0ji4cs7al4u3v9s47o